CAGLIO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 268
EU - Europa 217
AS - Asia 168
SA - Sud America 17
AF - Africa 1
Totale 671
Nazione #
US - Stati Uniti d'America 254
IT - Italia 110
SG - Singapore 79
CN - Cina 44
DE - Germania 33
BR - Brasile 12
CA - Canada 12
FR - Francia 12
JP - Giappone 12
GB - Regno Unito 11
IE - Irlanda 10
SE - Svezia 8
ID - Indonesia 7
BE - Belgio 6
FI - Finlandia 5
IN - India 5
NL - Olanda 5
TR - Turchia 5
AT - Austria 4
CH - Svizzera 4
VN - Vietnam 4
BD - Bangladesh 3
ES - Italia 3
KR - Corea 3
AR - Argentina 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
MX - Messico 2
PE - Perù 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CO - Colombia 1
ET - Etiopia 1
GR - Grecia 1
IQ - Iraq 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 671
Città #
Santa Clara 62
Singapore 47
Chandler 22
Munich 22
Turin 18
New York 12
Milan 11
Columbus 10
Dublin 10
Fairfield 8
Hefei 8
Paris 8
Rome 8
Beijing 7
Jakarta 7
Montreal 7
Nyköping 7
Boardman 6
Ashburn 5
Bologna 5
Ichikawa 5
London 5
Los Angeles 5
Medford 5
Seattle 5
Torino 5
Brussels 4
Frankfurt am Main 4
Istanbul 4
Tokyo 4
Wilmington 4
Düsseldorf 3
Hangzhou 3
Hebei 3
Hoffman 3
Olathe 3
Princeton 3
River Edge 3
Seoul 3
Silver Spring 3
Wakagi 3
Acri 2
Bari 2
Bayonne 2
Bhilai 2
Brno 2
Brookline 2
Buchs 2
Cambridge 2
Chengdu 2
Civitella del Tronto 2
Dhaka 2
Florence 2
Guangzhou 2
Helsinki 2
Lappeenranta 2
Lima 2
Liverpool 2
Marano di Napoli 2
Mexico City 2
Miami 2
Modena 2
Nuremberg 2
Pamplona 2
Pistoia 2
Pune 2
San Jose 2
Segrate 2
Tampa 2
Toronto 2
Trepuzzi 2
Upper Marlboro 2
Vancouver 2
Vienna 2
Woodbridge 2
Zurich 2
Altoona 1
Americana 1
Amsterdam 1
Ancona 1
Atibaia 1
Atlanta 1
Baku 1
Basra 1
Bethesda 1
Birmingham 1
Bogotá 1
Bolton 1
Boston 1
Buena Nueva 1
Burnaby 1
Cabo de Santo Agostinho 1
Central 1
Chongqing 1
Cleveland 1
Crateús 1
Dallas 1
Denver 1
Dias dávila 1
Enfield 1
Totale 464
Nome #
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review 217
Clinical and molecular features of epidermal growth factor receptor (Egfr) mutation positive non‐small‐cell lung cancer (nsclc) patients treated with tyrosine kinase inhibitors (tkis): Predictive and prognostic role of co‐mutations 102
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 101
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study 72
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study 49
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience 45
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020 42
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study 40
Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments 22
Totale 690
Categoria #
all - tutte 2.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/202278 15 5 4 5 3 2 2 0 0 6 21 15
2022/202396 10 11 3 7 4 19 13 9 5 3 12 0
2023/2024114 12 8 5 11 9 10 4 9 2 22 12 10
2024/2025371 46 9 16 30 67 37 15 21 31 13 29 57
2025/202623 23 0 0 0 0 0 0 0 0 0 0 0
Totale 690